|
FDA Approval Activities for this Drug
Mitomycin Injection, 5 mg/vial and 20 mg/vial SuperGen ANDA 64-144 4/30/98 5/6/98
Mitomycin for Injection USP, 5 mg/vial and 20 mg/vial. ESI Lederle ANDA 64-180 12/23/99 12/27/99
Mitozytrex (Mitomycin) Injection, USP, SuperGen, NDA 50-763 Mytozytrex (Mitomycin Injection)
Company: SuperGen NDA 50-763 MITOMYCIN Injection 20MG/VIAL MITOMYCIN Baxter 064180 MITOMYCIN Injection 5MG/VIAL MITOMYCIN Baxter 064117 MITOMYCIN Injection 20MG/VIAL MITOMYCIN Bedford 064117 MITOMYCIN Injection 5MG/VIAL MITOMYCIN Bedford 062336 MITOMYCIN Injection 20MG/VIAL MUTAMYCIN BRISTOL MYERS
062336 MITOMYCIN Injection 40MG/VIAL MUTAMYCIN BRISTOL MYERS
062336 MITOMYCIN Injection 5MG/VIAL MUTAMYCIN BRISTOL MYERS
064106 MITOMYCIN Injection 20MG/VIAL MITOMYCIN Faulding 064144 MITOMYCIN Injection 20MG/VIAL MITOMYCIN SUPERGEN
064144 MITOMYCIN Injection 5MG/VIAL MITOMYCIN SUPERGEN
050763 MITOMYCIN Injection 5MG/VIAL MYTOZYTREX SUPERGEN
Back to this API's Main Page.
|